Abstract:Abstract The dependence of the host on the interaction of hundreds of extracellular proteins with the cell surface glycosaminoglycan heparan sulphate (HS) for the regulation of homeostasis is exploited by many microbial pathogens as a means of adherence and invasion. The closely related polysaccharide heparin, the widely used anticoagulant drug, which is structurally similar to HS and is a common experimental proxy, can be expected to mimic the properties of HS. Heparin prevents infection by a range of viruses if added exogenously, including S-associated coronavirus strain HSR1. Heparin prevents infection by a range of viruses if added exogenously, including S-associated coronavirus strain HSR1. Here, we show that the addition of heparin to Vero cells between 6.25 - 200 μg.ml −1 , which spans the concentration of heparin in therapeutic use, and inhibits invasion by SARS-CoV-2 at between 44 and 80%. We also demonstrate that heparin binds to the Spike (S1) protein receptor binding domain and induces a conformational change, illustrated by surface plasmon resonance and circular dichroism spectroscopy studies. The structural features of heparin on which this interaction depends were investigated using a library of heparin derivatives and size-defined fragments. Binding is more strongly dependent on the presence of 2-O or 6-O sulphation, and the consequent conformational consequences in the heparin structure, than on N-sulphation. A hexasaccharide is required for conformational changes to be induced in the secondary structure that are comparable to those that arise from heparin binding. Enoxaparin, a low molecular weight clinical anticoagulant, also binds the S1 RBD protein and induces conformational change. These findings have implications for the rapid development of a first-line therapeutic by repurposing heparin as well as for next-generation, tailor-made, GAG-based antiviral agents against SARS-CoV-2 and other members of the Coronaviridae .

Heparin: an intervenor in cell communication.

The Role of Heparin Binding Surfaces in the Direction of Endothelial and Smooth Muscle Cell Fate and Re-Endothelialization

Perturbation of the Heparin/heparin-Sulfate Interactome of Human Breast Cancer Cells Modulates Pro-Tumourigenic Effects Associated with PI3K/Akt and MAPK/ERK Signalling

Heparan sulfate and heparin interactions with proteins

Anti- adhesion effects of heparin on endothelial cells

Heparin: Effects upon the Glycocalyx and Endothelial Cells.

Binding between the Integrin αXβ2 (CD11c/CD18) and Heparin

Binding between the integrin alphaXbeta2 (CD11c/CD18) and heparin.

The role of heparin/heparan sulphate in the IFN-γ-led Arena

Heparin inhibits cellular invasion by SARS-CoV-2: structural dependence of the interaction of the surface protein (spike) S1 receptor binding domain with heparin

Inhibition of Heparin to the Activation of T Lymphocytes and Its Mechanism

Surface plasmon resonance analysis to evaluate the importance of heparin sulfate groups' binding with human aFGF and bFGF

Pharmacology of Heparin and Related Drugs

Heparin Regulation of the Complement System

Heparin changes the conformation of high-mobility group protein 1 and decreases its affinity toward receptor for advanced glycation endproducts in vitro.

Experimental Study on the Relationship Between Heparin Sulfate Proteoglycans of Endothelial Cells and Cell Adhesion.

Heparin: an Old Drug for New Clinical Applications.

The Preventive and Therapeutic Effects of Acute and Severe Inflammatory Disorders with Heparin and Heparinoid

Heparin Inhibits Cellular Invasion by SARS-CoV-2: Structural Dependence of the Interaction of the Spike S1 Receptor-Binding Domain with Heparin

Not Just Anticoagulation—New and Old Applications of Heparin

Effect of Heparanase and Heparan Sulfate Chains in Hemostasis